Aegerion Pharmaceuticals, Inc. (AEGR) Posts Q2 Loss of 63c/Share

Article Stock Quotes (1) Comments (0)

Aegerion Pharmaceuticals, Inc. (NASDAQ: AEGR) reported Q2 EPS of ($0.63), $0.12 worse than the analyst estimate of ($0.51).

For earnings history and earnings-related data on Aegerion Pharmaceuticals, Inc. (AEGR) click here.

---

Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW

---

*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here

---

---

You May Also Be Interested In

• Hewlett-Packard Company (HPQ) Tops Q2 EPS by 6c as Sales Slide 10%
• UPDATE: 8x8 Inc. (EGHT) Misses Q4 EPS by 1c
• LTX-Credence Corp (LTXC) Misses Q3 EPS by 2c; Issues Weak Q4 Outlook

Create E-mail Alert Related Categories

Earnings

Related Entities

Earnings

Add Your Comment

Name

Subject

Body

Share on Facebook

Verification
can't see the text?
click here to refresh the image.
what's this?